Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 26, 1997

View Archived Issues

Pierre Fabre develops novel anticancer carpaine derivatives

Potent and selective progestogens from Theramex

R-PIA active in rodent model of neuropathic central pain

Melatonin for treatment of fibromyalgia syndrome

Astra describes prodrugs of thrombin inhibitors

Novel benzothiazolone ethanamines for airways diseases

News flash: new indication investigated for SR-57746A

HMR presents 5-HT3 antagonists for CNS disorders

Entacapone clinical and preclinical data reported at neurology congress

New Na+/H+-exchange inhibitors from Fujisawa

Synthetic studies on LAS-32521 reported

Design, synthesis and evaluation of SNAP-5582 derivatives for BPH

4030W92 preclinical activity and structure reported at Barcelona congress

Sildenafil continues to demonstrate efficacy in treating ED

CMI-947: new 5-LO inhibitor discovered at CytoMed

Metrifonate efficacy in AD demonstrated in clinical trial

Schering-Plough and Genome Therapeutics enter antifungal alliance

New taxoids with improved anticancer activity

New indication for lamotrigine tested in patients: ADHD

Broad-spectrum chemokine antagonist blocks HIV cell entry

Darwin Molecular and Geron investigate gene for premature aging

Cel-Sci and NCI collaborate on immunotherapy research for cancer

Lotemax deemed approvable by FDA

Filgrastim effects on lymphocytes in HIV infection

Baxter and Inhale commence phase II trial using pulmonary delivery system

Arris reports data from phase IIa asthma trial

Fluvastatin safely and effectively improves lipid profiles in transplant recipients

Guilford reports interim preclinical results with neurotrophic agent

Naramig safe and effective for acute treatment of migraine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...